Pure Bioscience, Inc. (PURE) Reports Q2 Loss of $0.05

Pure Bioscience, Inc. (NASDAQ: PURE) reported Q2 EPS of ($0.05), versus ($0.07) reported last year. Revenue for the quarter came in at $221 thousand, versus $68 thousand reported last year.

For earnings history and earnings-related data on Pure Bioscience, Inc. (PURE) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Benchmark on Take-Two's (TTWO) GTV 6 Release: 'we anticipate that the game will not be released within the fiscal year and expect it to launch in fiscal 2026 instead'
• P&G lifts annual profit forecast on strong US consumer demand, easing costs
• Procter & Gamble (PG) revenue falls short of expectations, raises full-year earnings guidance